Recombinant IL17A, IL17F (Bimekizumab Biosimilar) antibody (Biotin)

Catalog No. ABIN7850756

This Humanized Monoclonal antibody specifically detects IL17A, IL17F (Bimekizumab Biosimilar) . It exhibits reactivity toward Human.

Quick Overview for Recombinant IL17A, IL17F (Bimekizumab Biosimilar) antibody (Biotin) (ABIN7850756)

Target: IL17A, IL17F (Bimekizumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Humanized

Clonality: Monoclonal

Conjugate: This IL17A, IL17F (Bimekizumab Biosimilar) antibody is conjugated to Biotin

Application: Please inquire

Grade: Research Grade

Product Details anti-IL17A, IL17F (Bimekizumab Biosimilar) Antibody (Biotin)

Purpose: Biotinylated Anti-IL17A(bimekizumab biosimilar) mAb

Isotype: E356D, IgG1, M358L, kappa

Application Details

Comment:

Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.

Restrictions: For Research Use only

Handling

Format: Lyophilized

Reconstitution: Please see Certificate of Analysis for specific instructions of reconstitution.

Buffer: Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8 % trehalose is added as protectants before lyophilization.

Storage: -20 °C,-80 °C

Storage Comment: Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.

Expiry Date: 12 months

Target Details for IL17A, IL17F (Bimekizumab Biosimilar)

Target: IL17A, IL17F (Bimekizumab Biosimilar)

Alternative Name: Bimekizumab Biosimilar

Target Type: Biosimilar

Background: Synonyms Target:IL17,CTLA8,IL-17,ILA17,CTLA-8,IL-17A
Synonyms Antibody:Bimzelx,CDP-4940,CDP4940,UCB-4940,UCB4940

UniProt: Q16552